One – 8 Night Stay & 1 Phone Call
Clinical trial study. This investigational medication is being developed to treat obesity.
Males & Females
(Females must be of Non-Childbearing Potential).
Body Mass Index (BMI): 18.5-29.9
Screening Available in Omaha, NE on 3/29.
Celerion is offering a $500 travel voucher to participants traveling 150 or more miles from their home address to participate in this study.
Name of Clinical Site
621 Rose Street, Lincoln, NE, USA